Outcomes after endovascular mechanical thrombectomy for low compared to high National Institutes of Health Stroke Scale (NIHSS): A multicenter study.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
02 2023
Historique:
received: 19 09 2022
revised: 02 01 2023
accepted: 09 01 2023
pubmed: 20 1 2023
medline: 7 3 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

The role of endovascular mechanical thrombectomy (MT) in patients presenting with "minor" stroke is uncertain. We aimed to compare outcomes after MT for ischemic stroke patients presenting with National Institutes of Health Stroke Scale (NIHSS) 5 and - within the low NIHSS cohort - identify predictors of a favorable outcome, mortality, and symptomatic intracranial hemorrhage (ICH). We retrospectively analyzed a prospectively maintained, international, multicenter database. The study cohort comprised a total of 7568 patients from 29 centers. NIHSS was low (<5) in 604 patients (8%), and > 5 in 6964 (92%). Patients with low NIHSS were younger (67 + 14.8 versus 69.6 + 14.7 years, p < 0.001), more likely to have diabetes (31.5% versus 26.9%, p = 0.016), and less likely to have atrial fibrillation (26.6% versus 37.6%, p < 0.001) compared to those with higher NIHSS. Radiographic outcomes (TICI > 2B 84.6% and 84.3%, p = 0.412) and complication rates (8.1% and 7.2%, p = 0.463) were similar between the low and high NIHSS groups, respectively. Clinical outcomes at every follow up interval, including NIHSS at 24 h and discharge, and mRS at discharge and 90 days, were better in the low NIHSS group, however patients in the low NIHSS group experienced a relative decline in NIHSS from admit to discharge. Mortality was lower in the low NIHSS group (10.4% versus 24.5%, p < 0.001). Relative to patients with high NIHSS, MT is safe and effective for stroke patients with low NIHSS, and it is reasonable to offer it to appropriately selected patients presenting with minor stroke symptoms. Our findings justify efforts towards a randomized trial comparing MT versus medical management for patients with low NIHSS.

Identifiants

pubmed: 36657358
pii: S0303-8467(23)00008-2
doi: 10.1016/j.clineuro.2023.107592
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107592

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Auteurs

Isaac Josh Abecassis (IJ)

Department of Neurological Surgery University of Louisville, Louisville, KY, USA. Electronic address: Isaac.Abecassis@uoflhealth.org.

Eyad Almallouhi (E)

Department of Neurological Surgery Medical University of South Carolina, Charleston, SC, USA.

Reda Chalhoub (R)

Department of Neurological Surgery Medical University of South Carolina, Charleston, SC, USA.

Sami Al Kasab (SA)

Department of Neurological Surgery Medical University of South Carolina, Charleston, SC, USA.

Eric Bass (E)

Department of Neurological Surgery Medical University of South Carolina, Charleston, SC, USA.

Dale Ding (D)

Department of Neurological Surgery University of Louisville, Louisville, KY, USA.

Vasu Saini (V)

Department of Neurological Surgery University of Miami, Miami, FL, USA.

Joshua D Burks (JD)

Department of Neurological Surgery University of Miami, Miami, FL, USA.

Ilko L Maier (IL)

Department of Neurology University Medicine Göttingen, Germany.

Marios-Nikos Psychogios (MN)

Department of Neuroradiology University Hospital Basel, Switzerland.

Jan Liman (J)

Department of Neurology University Medicine Göttingen, Germany.

Ali Alawieh (A)

Department of Neurosurgery Emory University School of Medicine, Atlanta, GA, USA.

Stacey Wolfe (S)

Department of Neurological Surgery Wake Forest School of Medicine, Winston Salem, NC, USA.

Adam S Arthur (AS)

Department of Neurosurgery Semmes-Murphey Neurologic and Spine Clinic, University of Tennessee Health Science Center, Memphis, TN, USA.

Amir Shaban (A)

Department of Neurology University of Iowa, Iowa City, IA, USA.

Travis Dumont (T)

Department of Neurosurgery University of Arizona Health Sciences, Tucson, AZ, USA.

Peter Kan (P)

Department of Neurosurgery University of Texas Medical Branch at Galveston, Galveston, TX, USA.

Joon-Tae Kim (JT)

Department of Neurology Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, South Korea.

Reade De Leacy (R)

Department of Neurosurgery Mount Sinai Health System, New York, NY, USA.

Joshua Osbun (J)

Department of Neurosurgery Washington University of School of Medicine, St.Louis, MO, USA.

Ansaar Rai (A)

Department of Radiology West Virginia School of Medicine, Morgantown, WV, USA.

Pascal Jabbour (P)

Department of Neurosurgery Thomas Jefferson University Hospitals, Philadelphia, PA, USA.

Jonathan A Grossberg (JA)

Department of Neurosurgery Emory University School of Medicine, Atlanta, GA, USA.

Min S Park (MS)

Department of Neurosurgery University of Virginia, Charlottesville, VA, USA.

Roberto Crosa (R)

Department of Neurosurgery Endovascular Neurological Center, Montevideo, Uruguay.

Justin Mascitelli (J)

Department of Neurosurgery University of Texas Health Science Center at San Antonio, TX, USA.

Michael R Levitt (MR)

Department of Neurosurgery University of Washington, Seattle, WA, USA.

Adam Polifka (A)

Department of Neurosurgery University of Florida, Gainesville, FL, USA.

Walter Casagrande (W)

Department of Cerebrovascular and Endovascular Neurosurgery Hospital Juan Fernandez, Buenos Aires, Argentina.

Shinichi Yoshimura (S)

Department of Neurosurgery Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Charles Matouk (C)

Department of Neurosurgery Yale School of Medicine, New Haven, CT, USA.

Richard W Williamson (RW)

Department of Neurosurgery Allegheny Health Network, Pittsburgh, PA, USA.

Benjamin Gory (B)

Department of Diagnostic and Therapeutic Neuroradiology Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.

Maxim Mokin (M)

Department of Neurosurgery University of South Florida, Tampa, Florida, USA.

Isabel Fragata (I)

Neuroradiology Department Hospital São José Centro Hospitalar, Lisboa, Portugal.

Daniele G Romano (DG)

Department Neuroradiology, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.

Shakeel Chowdry (S)

Department of Neurosurgery NorthShore University Health System, Evanston, IL, USA.

Mark Moss (M)

Department of Interventional Neuroradiology Washington Regional Medical Center, Fayetteville, AR, USA.

Daniel Behme (D)

Department of Neuroradiology University Hospital Magdeburg, Germany.

Kaustubh Limaye (K)

Departments of Neurology, Neurological Surgery, and Radiology Indiana University, Indianapolis, IN, USA.

Alejandro M Spiotta (AM)

Department of Neurological Surgery Medical University of South Carolina, Charleston, SC, USA.

Robert M Starke (RM)

Department of Neurological Surgery University of Miami, Miami, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH